Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the infanrix and infanrix-hexa market grown in recent years?

In recent years, the market size for Infanrix and Infanrix-Hexa has seen a HCAGR of XX. Projected growth indicates a rise from $XX million in 2024 to $XX million in 2025, representing a compound annual growth rate (CAGR) of XX%. The market expansion experienced during the historic period is largely due to factors such as a heightened awareness of diseases that can be prevented through vaccination, an increase in government-run immunization initiatives, rising consciousness about poliovirus diseases, a boost in worldwide immunization efforts, increased understanding about child health care, and the broadening of healthcare infrastructure.

How is the infanrix and infanrix-hexa market size expected to evolve during the forecast period?

Anticipated projections for the infanrix and infanrix-hexa market suggest a forecasted compound annual growth rate of XX% over the approaching years, reaching a value of $XX million by 2029. This projected growth during the forecast period is a consequence of factors such as the surge in worldwide immunization efforts, the escalating prevalence of diseases preventable through vaccination, the extension of healthcare availability in developing economies, encouraging governmental policies and funding, and an increased consciousness regarding pediatric immunization. Other future trends encompass advancements in cold chain logistics and digital vaccine tracking systems, innovation in vaccine formulations, progress in vaccine delivery technologies, and the evolution of combination vaccines.

Get your infanrix and infanrix-hexa market report here!

https://www.thebusinessresearchcompany.com/report/infanrix-and-infanrix-hexa-global-market-report

Which key drivers are propelling the infanrix and infanrix-hexa market’s growth?

The surge in the number of reported pertussis cases, also known as whooping cough, is predicted to fuel the expansion of the Infanrix and Infanrix-hexa market. Factors contributing to this surge include decreased vaccination rates, changes in immunity levels, and an increase in undiscovered or misidentified cases of this highly communicable respiratory illness. The escalating number of pertussis cases is boosting the demand for the Infanrix and Infanrix-hexa vaccines which effectively counteract this highly infectious disease, leading to their higher utilization and consequent market expansion. For example, the Health Protection Surveillance Centre, an Irish agency specializing in communicable disease surveillance, reported a noteworthy increase in pertussis cases in Ireland in October 2024, from 18 cases in 2023 to approximately 514 in 2024. Furthermore, there were 7 cases reported in 2022, and 5 in 2021. Therefore, the escalating prevalence of pertussis is expected to stimulate the growth of the Infanrix and Infanrix Hexa vaccine market.

What are the market segments in the infanrix and infanrix-hexa industry?

The infanrix and infanrix-hexa market covered in this report is segmented –

1) By Patient Demographics: Infants; Children; Adolescents And Adults

2) By Clinical Indication: Diphtheria; Tetanus; Pertussis (Whooping Cough); Hepatitis B; Poliomyelitis; Haemophilus Influenzae Type B (Hib)

3) By Distribution Channel: Hospitals; Clinics; Public Health Programs; Pharmacies

4) By Application: Primary Vaccination; Booster Doses; Combination With Other Vaccines

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20314&type=smp

Which leading companies are shaping the growth of the infanrix and infanrix-hexa market?

Major companies operating in the infanrix and infanrix-hexa market are GlaxoSmithKline plc

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20314

Which geographic areas are influencing the growth of the infanrix and infanrix-hexa market?

North America was the largest region in the infanrix and infanrix-hexa market in 2024. The regions covered in the infanrix and infanrix-hexa market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Diphtheria Global Market Report 2025

https://thebusinessresearchcompany.com/report/diphtheria-global-market-report

Non-Alcoholic Steatohepatitis Biomarkers Global Market Report 2025

https://thebusinessresearchcompany.com/report/non-alcoholic-steatohepatitis-biomarkers-global-market-report

Hepatitis B Virus (HBV) Global Market Report 2025

https://thebusinessresearchcompany.com/report/hepatitis-b-virus-hbv-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: